A new pill has been approved for NHS use, offering a significant reduction in the risk of certain breast cancers recurring.
The decision by the National Institute for Health and Care Excellence (Nice) is expected to benefit about 4,000 people.
A new pill has been approved for NHS use, offering a significant reduction in the risk of certain breast cancers recurring.
The decision by the National Institute for Health and Care Excellence (Nice) is expected to benefit about 4,000 people.